ClinicalTrialsFinder

Stage III Squamous Cell Carcinoma of the Head and Neck Clinical Trials in Bethesda, Maryland

1 recruitingBethesda, Maryland

Showing 1–1 of 1 trials

Recruiting
Phase 2

Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell Carcinoma

Stage II Squamous Cell Carcinoma of the Head and NeckStage III Squamous Cell Carcinoma of the Head and NeckStage IV Squamous Cell Carcinoma of the Head and Neck
National Cancer Institute (NCI)40 enrolled1 locationNCT06161545